V CompBrief BY VELARION

Chief Strategy Officer · OCULAR THERAPEUTIX, INC (OCUL)

Sanjay Nayak

FY2025 is the first fiscal year CompBrief holds for Sanjay Nayak as a named executive officer of OCULAR THERAPEUTIX; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,463,405

4th of 5 named executive officers at Ocular Therapeutix by FY2025 total.

5 named officers on file for OCULAR THERAPEUTIX, FY2025

See an example →

What this number hides

The filing gives the total. OCULAR THERAPEUTIX’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how OCULAR THERAPEUTIX’s whole pay program stands against its peers

  • OCULAR THERAPEUTIX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OCUL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get Sanjay Nayak’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Sanjay Nayak and every company like it: Velarion Intel, free for 3 days, no card →

Sanjay Nayak compensation by year

OCULAR THERAPEUTIX Summary Compensation Table · the one fiscal year held
In US dollars, as OCULAR THERAPEUTIX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$510,000
Bonus$332,775
Stock awards$825,840
Option awards$1,791,912
Non-equity incentive$0
Pension and deferred compensation$0
All other$2,878
Total$3,463,405

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 30, 2026, accession 0001104659-26-053176, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OCULAR THERAPEUTIX, INC filed document, accession 0001104659-26-053176. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU111,000$1,347,540—
RSU33,548$406,180—
Option264,418—$7.44
Option132,466—$9.70

Per the Outstanding Equity Awards at Fiscal Year-End table in OCULAR THERAPEUTIX, INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed April 30, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-24Sale10b5-11,897$10.78326,898
2026-05-26Sale10b5-11,858$8.20328,795

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments OCULAR THERAPEUTIX discloses, by trigger · FY2025
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$510,000$3,319,702—$3,829,702
Change in control and involuntary termination$765,000$3,319,702—$4,428,952

Per the Potential Payments Upon Termination or Change in Control table in OCULAR THERAPEUTIX, INC's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.

OCULAR THERAPEUTIX’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Pravin DugelExecutive Chairman, President and Chief Executive Officer$35,946,958
Nadia WaheedChief Medical Officer$4,378,925
Donald NotmanChief Financial Officer and Chief Operating Officer$3,670,959
Sanjay Nayak · this pageChief Strategy Officer$3,463,405
Steve MeyersChief Commercial Officer$2,550,269

Sanjay Nayak's compensation dossier, OCULAR THERAPEUTIX

You have read Sanjay Nayak's totals and holdings. The dossier adds each equity grant OCULAR THERAPEUTIX disclosed for Sanjay Nayak and OCULAR THERAPEUTIX's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full OCULAR THERAPEUTIX compensation record

free company brief
OCULAR THERAPEUTIX, INC (OCUL) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within OCULAR THERAPEUTIX's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the OCULAR THERAPEUTIX proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order OCULAR THERAPEUTIX's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCULAR THERAPEUTIX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order OCUL

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Sanjay Nayak's compensation dossier